TLDR About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.
In a cross-sectional study of 1,000 high school girls aged 14-18 in Isfahan, Iran, the prevalence of clinical polycystic ovary syndrome (PCOS) was determined to be 3%. The study identified hirsutism in 6% of participants, menstrual dysfunction in 7.4%, and severe acne in 4.7%. Diagnosis of clinical PCOS was based on the presence of menstrual dysfunction and clinical hyperandrogenism, without hormonal assessments. The findings indicated that PCOS prevalence in this population was consistent with other studies, but the actual prevalence might be underestimated due to the lack of hormonal evaluations. The study highlighted the need for more comprehensive investigations, including hormonal and ultrasonographic assessments, to accurately determine PCOS prevalence among adolescents in Isfahan.
298 citations,
July 2000 in “The Journal of Clinical Endocrinology and Metabolism” About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.
75 citations,
June 1999 in “Pediatric Clinics of North America” The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.
378 citations,
September 1998 in “The Journal of Clinical Endocrinology and Metabolism” PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.
3 citations,
August 2019 in “Journal of The American Academy of Dermatology” Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.
1 citations,
August 2013 in “Springer eBooks” Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.
10 citations,
November 2010 in “Skin therapy letter” Women with PCOS often have acne because of high androgen levels, and the article reviewed how to treat this type of acne.
20 citations,
June 2010 in “International Journal of Dermatology” Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.
52 citations,
June 1999 in “Endocrinology and Metabolism Clinics of North America” Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.
